Bruker Corporation (NASDAQ: BRKR) has reported E.P.S. of $0.09 for its fourth fiscal quarter (ending December 31) versus $1.41 for the same period a year ago — a decline of -94%. Relative to the consensus estimate of $0.74, this was a shortfall of $-0.65. E.P.S. were $0.76 for the latest four quarters through December 31 versus $2.92 for the same period a year ago — a decline of -74%.
Recent Price Action
Bruker Corporation (NASDAQ: BRKR) stock declined slightly by -1.0% on 2/13/25. The stock closed at $51.15. Moreover, exceptionally high trading volume at 209% of normal accompanied the decline. Relative to the market the stock has been weak over the last nine months and has declined -10.9% during the last week.
Current PriceTarget Research Rating
Bruker has a current Value Trend Rating of F (Lowest Rating). This rating combines consistent signals from two proprietary PTR measures of a stock’s attractiveness. Bruker has a slightly negative Appreciation Score of 30 and a poor Power Rating of 21, and the Lowest Value Trend Rating results.
Rating Review
In light of this discouraging new earnings information and negative market action we are reviewing our current Overall Rating of F. We would continue to view the shares with caution pending completion of this review in the next several days.
Be the first to comment